<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02710487</url>
  </required_header>
  <id_info>
    <org_study_id>EOC.NSI.LS.15.3.II</org_study_id>
    <nct_id>NCT02710487</nct_id>
  </id_info>
  <brief_title>Sleep, Awake &amp; Move - Part II</brief_title>
  <acronym>SA&amp;M-II</acronym>
  <official_title>Awake &amp; Move. Role of Nocturnal Sleep and Rapid Eye Movement Sleep at Morning Awakening on Sleep Benefit in Parkinson's Disease. An Interventional Cross-over Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neurocenter of Southern Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Parkinson Schweiz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ente Ospedaliero Cantonale, Bellinzona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Neurocenter of Southern Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep benefit (SB) is a prominent spontaneous, apparently unpredictable, transitory
      improvement in motor function reported by around 50% of patients affected by Parkinson's
      Disease (PD) after sleep and before taking their first dose of dopaminergic medications. The
      aim of this study is to test the hypothesis that objective and/or subjective improvement of
      motor function might be due to a carry-over effect of Rapid Eye Movements (REM) sleep at
      awakening from this sleep phase.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The &quot;Awake &amp; Move&quot; study is the second part of the Sleep, Awake &amp; Move project. This study
      will be conducted in a subgroup of unselected, consecutive patients having completed the part
      I of the Sleep, Awake &amp; Move project (i.e. the &quot;Sleep &amp; Move&quot; study). The investigators plan
      to explore the carry-over effect of REM sleep on motor function in a subgroup of PD subjects
      p. In this interventional study the investigators expect to induce SB by awakening the
      subjects from nocturnal REM sleep in a sleep laboratory setting, but not from Non-Rapid Eye
      Movements (NREM) sleep (control intervention).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overnight change in objective motor performance</measure>
    <time_frame>12 hours</time_frame>
    <description>The change of objective measures of morning motor performance at awakening from REM sleep compared to the morning motor performance at awakening from NREM sleep (stage N2), within the same subjects, by mean of an electronic finger tapping test and the Movement Disorders Society Unified Parkinson's Disease Rating Scale motor examination (MDS-UPDRS-III).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overnight change in subjective motor performance</measure>
    <time_frame>12 hours</time_frame>
    <description>The change of subjective measures of morning motor performance at awakening from REM sleep compared to the morning motor performance at awakening from NREM sleep (stage N2), within the same subjects, by mean of the Scale for Outcome in Parkinson's Disease Diary Card (SCOPA-DC) and a visual analogue scale (VAS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Idiopathic Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>REM Sleep Awakening (REMSA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators will actively awaken each subject from nocturnal REM sleep in a sleep laboratory setting, in the hour preceding her/his habitual wake time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NREM Sleep Awakening (NREMSA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Awakening from the NREM sleep stage N2 will be the control intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>REMSA</intervention_name>
    <description>Awakening from REM sleep during the last hour of the sleep period</description>
    <arm_group_label>REM Sleep Awakening (REMSA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>NREMSA</intervention_name>
    <description>Awakening from N2 (NREM) sleep during the last hour of the sleep period</description>
    <arm_group_label>NREM Sleep Awakening (NREMSA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnostic criteria of idiopathic Parkinson's disease (UKPDBB)

          -  Mild to moderate disease (Hoehn &amp; Yahr score ≥ 1 and &lt; 3)

          -  Mentally and physically capable to give informed consent

          -  Stable antiparkinsonian and psychotropic therapy for the last 30 days

        Exclusion Criteria:

          -  Atypical parkinsonian syndrome

          -  Cognitive impairment (MMSE ≥ 26)

          -  Deep brain stimulation

          -  History of cerebro-vascular disease, epilepsy, or other disabling neurological
             diseases

          -  Psychiatric disorders, excepting mild depression

          -  Alcohol abuse

          -  Other clinically significant severe concomitant disease states

          -  Inability to follow the procedures of the study (e.g. due to language problems,
             psychological disorders, etc.)

          -  Participation in another study with investigational drug within the 60 days preceding
             and during the present project.

          -  subjects with (a) sleep-disordered breathing [Respiratory Disorder Index (RDI)≥ 5] and
             (b) with no clear-cut distinction of REM and NREM sleep, based on a
             video-polysomongraphical recording.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pietro Luca Ratti, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep and Epilepsy center Department of Neurology, Neurocenter of Southern Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pietro Luca Ratti, MD, PhD</last_name>
    <phone>+41(0)918116849</phone>
    <email>PietroLuca.Ratti@eoc.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ninfa Amato, PhD</last_name>
    <phone>+41(0)795553120</phone>
    <email>Ninfa.Amato@eoc.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sleep and Epilepsy center Department of Neurology, Neurocenter of Southern Switzerland</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pietro Luca Ratti, MD, PhD</last_name>
      <phone>+41(0)918116849</phone>
      <email>PietroLuca.Ratti@eoc.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ninfa Amato, PhD</last_name>
      <phone>+41(0)795553120</phone>
      <email>Ninfa.Amato@eoc.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Pietro Luca Ratti, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain Kälin-Lang, Pr, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ninfa Amato, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Miano, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Hackethal, Med. Stud.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>De Cock VC, Vidailhet M, Leu S, Texeira A, Apartis E, Elbaz A, Roze E, Willer JC, Derenne JP, Agid Y, Arnulf I. Restoration of normal motor control in Parkinson's disease during REM sleep. Brain. 2007 Feb;130(Pt 2):450-6.</citation>
    <PMID>17235126</PMID>
  </reference>
  <reference>
    <citation>Stefani A, Galati S, Peppe A, Bassi A, Pierantozzi M, Hainsworth AH, Bernardi G, Orlacchio A, Stanzione P, Mazzone P. Spontaneous sleep modulates the firing pattern of parkinsonian subthalamic nucleus. Exp Brain Res. 2006 Jan;168(1-2):277-80. Epub 2005 Nov 18.</citation>
    <PMID>16328297</PMID>
  </reference>
  <reference>
    <citation>Urrestarazu E, Iriarte J, Alegre M, Clavero P, Rodríguez-Oroz MC, Guridi J, Obeso JA, Artieda J. Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease. Mov Disord. 2009 Jan 30;24(2):254-60. doi: 10.1002/mds.22351.</citation>
    <PMID>18951542</PMID>
  </reference>
  <reference>
    <citation>van Gilst MM, Bloem BR, Overeem S. &quot;Sleep benefit&quot; in Parkinson's disease: a systematic review. Parkinsonism Relat Disord. 2013 Jul;19(7):654-9. doi: 10.1016/j.parkreldis.2013.03.014. Epub 2013 Apr 21. Review.</citation>
    <PMID>23615667</PMID>
  </reference>
  <reference>
    <citation>Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson's disease. Mov Disord. 1997 Jul;12(4):506-8.</citation>
    <PMID>9251067</PMID>
  </reference>
  <reference>
    <citation>Currie LJ, Bennett JP Jr, Harrison MB, Trugman JM, Wooten GF. Clinical correlates of sleep benefit in Parkinson's disease. Neurology. 1997 Apr;48(4):1115-7.</citation>
    <PMID>9109914</PMID>
  </reference>
  <reference>
    <citation>Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord. 1999 Nov;14(6):922-7.</citation>
    <PMID>10584665</PMID>
  </reference>
  <reference>
    <citation>Bateman DE, Levett K, Marsden CD. Sleep benefit in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):384-5.</citation>
    <PMID>10449564</PMID>
  </reference>
  <reference>
    <citation>Sherif E, Valko PO, Overeem S, Baumann CR. Sleep benefit in Parkinson's disease is associated with short sleep times. Parkinsonism Relat Disord. 2014 Jan;20(1):116-8. doi: 10.1016/j.parkreldis.2013.09.005. Epub 2013 Sep 12.</citation>
    <PMID>24084381</PMID>
  </reference>
  <reference>
    <citation>Högl BE, Gómez-Arévalo G, García S, Scipioni O, Rubio M, Blanco M, Gershanik OS. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease. Neurology. 1998 May;50(5):1332-9.</citation>
    <PMID>9595983</PMID>
  </reference>
  <reference>
    <citation>Högl B, Peralta C, Wetter TC, Gershanik O, Trenkwalder C. Effect of sleep deprivation on motor performance in patients with Parkinson's disease. Mov Disord. 2001 Jul;16(4):616-21.</citation>
    <PMID>11481684</PMID>
  </reference>
  <reference>
    <citation>Högl B, Gershanik O. Sleep benefit in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):798-9.</citation>
    <PMID>10877630</PMID>
  </reference>
  <reference>
    <citation>Factor SA, Weiner WJ. 'Sleep benefit' in Parkinson's disease. Neurology. 1998 May;50(5):1514-5.</citation>
    <PMID>9596032</PMID>
  </reference>
  <reference>
    <citation>Noyce AJ, Nagy A, Acharya S, Hadavi S, Bestwick JP, Fearnley J, Lees AJ, Giovannoni G. Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function. PLoS One. 2014 Apr 29;9(4):e96260. doi: 10.1371/journal.pone.0096260. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105488.</citation>
    <PMID>24781810</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2016</study_first_submitted>
  <study_first_submitted_qc>March 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2016</study_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neurocenter of Southern Switzerland</investigator_affiliation>
    <investigator_full_name>Pietro Luca Ratti</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease, Sleep Benefit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

